483
Dipakkumar P. Pandya, M.D.FDA 483 - Dipakkumar P. Pandya, M.D. - February 01, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Dipakkumar P. Pandya, M.D. in Annandale, NJ, revealed significant deviations from clinical study protocols and inadequate record-keeping. The firm failed to conduct required safety assessments, monitor investigational product storage, and maintain complete and correct informed consent forms and subject data. These issues indicate a lack of adherence to good clinical practice during the study.
Open in Dashboard
ID · c13ee1be-222d-4b62-ad8f-f8aa2b49ca31